medigraphic.com
ISSN 1561-3011 (Digital)

2011, Número 4

<< Anterior

Rev Cubana Invest Bioméd 2011; 30 (4)


Complicaciones del cardioversor-desfibrilador automático implantable. Tormenta eléctrica arrítmica

Dorantes SM

Idioma: Español
Referencias bibliográficas: 44
Paginas: 537-554
Archivo PDF: 194.51 Kb.


RESUMEN

El servicio de arritmias y estimulación eléctrica programada del corazón es centro nacional de referencia de los pacientes con cardiopatía estructural o sin ella y arritmias ventriculares malignas, para precisar diagnósticos y tomar las medidas terapéuticas adecuadas, principalmente la implantación del cardioversor-desfibrilador automático. Desde hace 24 años se implantan estos dispositivos y se observó lo frecuente de sus complicaciones (con inclusión de la tormenta eléctrica), en coincidencia con la literatura. Se elaboró una serie propia, cuyos datos se han publicado y presentado. Ahora se intenta una panorámica del problema. El dispositivo salva la vida y tiene indicaciones precisas, se requiere una adecuada primera decisión porque de lo contrario resultan mayores los riesgos que los beneficios. No debe dejar de implantarse en quien sea necesario, pero tampoco se debe colocar sin una indicación precisa, en alguien que no va a utilizarlo pero sí a enfrentarse con todos sus problemas de por vida pues una vez implantado nadie ya se atreverá a retirarlo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cannom DS, Prystowksy EN. Naspe history series. The evolution of the implantable cardioverter defibrillator. PACE. 2004;27:419-31.

  2. Josephson M, Wellens HJJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109:2685-91.

  3. Sears SF, Conti JB. Review. Understarding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26:107-11.

  4. Jordaens LJ, Mekel JM. Editorial. Electrical storm in the ICD era. Europace. 2005;7:181-3.

  5. Credner SC, Klingenheben Th, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: Incidence, management and prognostic implications. JACC. 1998;32:1909-15.

  6. Freedberg NA, Hill JN, Fogel RI, Prystowsky EN. Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy. Implications for antiarrhythmic therapy and driving restrictions. JACC. 2001;37:1910-5.

  7. Krivan L, Kozák M, Sepsi M, Svobodnik A, Spinar J. Specific complications in the treatment with implantable cardioverter-defibrillators. Cas Lek Cesk. 2004;143:521-5.

  8. Emori T, Ohta K, Kusano K, Morita H, Matsubara H, Sano Sh, et al. Clusters of ventricular fibrillation in a patient with an implantable cardioverter defibrillator treated with amiodarona. Circ J. 2003;67:163-5.

  9. Salukhe TV, Dimopoulos K, Sutton R, Coats A-J, Piepoli M, Francis DP. Life-years gained from defibrillator implantation. Markedly nonlinear increase during 3 years of follow-up and its implications. Circulation. 2004;109:1848-53.

  10. Senesi M. Cardiodefibriladores. Indicaciones convencionales y no convencionales. En: Valero EM, ed. Tratamiento eléctrico de las arritmias. Marcapasos y cardiodefibriladores. Buenos Aires: Editorial Tiempo; 2000. p. 187-92.

  11. Saksena S, Breithardt G, Dorian P, Greene HL, Madan N, Block M. Non pharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. Progress in Cardiovascular Diseases. 1996;38:429-44.

  12. Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug administration manufacturer and user facility device experience database. Heart Rhythm. 2004;4:399-405.

  13. Saksena S, Madan N. Clinician update. Management of the patient with an implantable cardioverter-defibrillator in the third millennium. Circulation. 2002;106:2642-6.

  14. Exner DV, Pinski SL, Wyse G, Renfroe EG, Follman D, Gold M, et al. Electrical storm presages non sudden death. The antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001;103:2066-71.

  15. Pinski SL. Emergencies related to implantable cardioverter-defibrillators. Crit Care Med. 2000;28(10 suppl):N174-80.

  16. Gradaus R, Block M, Brachmann J, Breithardt G, Huber HG, June W, et al. Mortality, morbidity and complications in 3 344 patients with implantable cardioverter defibrillators: results from the german ICD registry EU RID. PACE. 2003;26[Pt 1]:1511-8.

  17. Pinski SL, Fahy GJ. Current perspectives. The proarrhythmic potential of implantable cardioverterdefibrillators. Circulation. 1995;92:1651-64.

  18. Healy E, Gyal S, Browning C, Robotis D, Ramaswamy K, Rofino-Nadoworny K, et al. Inappropriate ICD therapy due to proarrhythmic ICD shocks and hyperpolarization. PACE. 2004;27:415-6.

  19. Perkiomaki JS, Couderc J-PH, Daubert JP, Zareba W. Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators. PACE. 2003;26:1931-6.

  20. Duru F, Candinas R. Potential proarrhythmic effects of implantable cardioverterdefibrillators. Clin Cardiol. 1999;22:139-46.

  21. Verma A, Kilicaslan F, Marrouche NF, Minor S, Khan M, Wazni O, et al. Prevalence, predictors and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiology. 2004;15:1265-70.

  22. Mok N-Sh, Chan N-Y, Chiu A Ch-S. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. PACE. 2004;27:821-3.

  23. Schliamser JE, Avramovitch NA, Karkabi B, Flugelman MY, Militianu A, Lewis BS. Rhabdomyolisis induced by repeated internal cardioverter defibrillator discharges. PACE. 2002;25:516-7.

  24. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Sotiropoulos E, Zervopoulos G, Antoniou J, et al. Electrical storm is an independent predictor of adverse long-term out come in the era of implantable defibrillator therapy. Europace. 2005;7:184-92.

  25. Greene M, Newman D, Geist M, Paquette M, Heng D, Dorian P. Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. Europace. 2000;2:263-9.

  26. Dorian P, Cass D. An overview of the management of electrical storm. Can J Cardiol. 1997;13(suppl A):13A-7A.

  27. Dorian P. Etiologies of electrical storm. Arch Mal Coeur Vaiss. 1997;90:27-31.

  28. Srivatsa UN, Ebrahimi R, El-Bialy A, Wachsner RY. Electrical storm: case series and review of management. J Cardiovasc Pharmacol Ther. 2003;8:237-46.

  29. Manolis AG, Katsivas AG, Vassilopoulos C, Tsatiris CG. Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination. J Interv Card Electrophysiol. 2002;6:91-4.

  30. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace. 2004;6:130-3.

  31. Silva RMFL, Mont Ll, Nava S, Rojel U, Matas M, Brugada J. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator. PACE. 2004;27:971-5.

  32. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445-52.

  33. Nakamura M, Isobe M, Imamura H. Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int Jcardiol. 1998;64:205-6.

  34. Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P. Near fatal electrical storm in a patient equiped with an implantable cardioverter defibrillator for Brugada syndrome. PACE. 2000;23:410-2.

  35. Arya A, Haghjoo M, Dehghani MR, Fazelifar AF, Nikoo MH, Bagherzadeh A, et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol. 2006;97:389-92.

  36. Block M, Breithardt G: Long-term follow-up and clinical results of implantable cardioverter-defibrillators. En: Zipes DP, Jalife J ed. Cardiac Electrophysiology: From cell to bedside. Philadelphia: W.B. Saunders; 1995:1412-25.

  37. Sinha SK, Mehta D, Gomes JA: Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator. Mt Sinai J Med. 2005;72:1-9.

  38. Brigadeau F, Kouakam C, Klug D, Marquie C, Duhamel A, Mizon-Gerard F, et al. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter-defibrillators. Eur Heart J. 2006;27:700-7.

  39. Bettiol K, Gianfranchi L, Scarfo S, Pacchioni F, Pedaci M, Alboni P. Successful treatment of electrical storm with oral quinidine in Brugada syndrome. Ital Heart J. 2005;6:601-2.

  40. Pinter A, Dorian P. Approach to antiarrhythmic therapy in patients with ICDs and frequent activations. Curr Cardiol Rep. 2005;7:376-81.

  41. Germano JJ, Reynolds M, Essebag V, Josephson ME. Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? Am J Cardiol. 2006;97:1255-61.

  42. Tornés F, Cisneros P, Dorantes M, Castro J, Zayas R, Quiñones MA, et al. Tormenta eléctrica arrítmica en pacientes con cardioversor-desfibrilador automático implantable. Arch Cardiol Mex. 2008;78:68-78.

  43. Josephson ME. Electrophysiology at a crossroads. Heart Rhythm. 2007;4;658-61.

  44. Klein GJ. Electrophysiology at crossroads: a time of great opportunity. Heart Rhythm. 2007;4:662-4.




2020     |     www.medigraphic.com